Citadel Advisors’s LifePoint Health, Inc. LPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-16,000
| Closed | -$1.03M | – | 10364 |
|
|
2018
Q3 | $1.03M | Buy |
16,000
+5,400
| +51% | +$329K | ﹤0.01% | 5487 |
|
|
2018
Q2 | $517K | Buy |
10,600
+2,900
| +38% | +$150K | ﹤0.01% | 6309 |
|
|
2018
Q1 | $362K | Sell |
7,700
-500
| -6% | -$24.1K | ﹤0.01% | 6445 |
|
|
2017
Q4 | $408K | Buy |
+8,200
| New | +$407K | ﹤0.01% | 5966 |
|
|
2016
Q3 | – | Sell |
-5,100
| Closed | -$333K | – | 8349 |
|
|
2016
Q2 | $333K | Sell |
5,100
-1,500
| -23% | -$102K | ﹤0.01% | 5067 |
|
|
2016
Q1 | $457K | Sell |
6,600
-1,600
| -20% | -$107K | ﹤0.01% | 4536 |
|
|
2015
Q4 | $602K | Buy |
8,200
+100
| +1% | +$7.11K | ﹤0.01% | 4214 |
|
|
2015
Q3 | $574K | Sell |
8,100
-2,200
| -21% | -$178K | ﹤0.01% | 4612 |
|
|
2015
Q2 | $896K | Hold |
10,300
| – | – | ﹤0.01% | 4109 |
|
|
2015
Q1 | $757K | Sell |
10,300
-9,300
| -47% | -$660K | ﹤0.01% | 4319 |
|
|
2014
Q4 | $1.41M | Buy |
19,600
+12,000
| +158% | +$831K | ﹤0.01% | 3333 |
|
|
2014
Q3 | $526K | Buy |
7,600
+3,200
| +73% | +$225K | ﹤0.01% | 4549 |
|
|
2014
Q2 | $273K | Sell |
4,400
-1,700
| -28% | -$99.7K | ﹤0.01% | 5183 |
|
|
2014
Q1 | $333K | Buy |
6,100
+4,800
| +369% | +$257K | ﹤0.01% | 4893 |
|
|
2013
Q4 | $69K | Sell |
1,300
-2,600
| -67% | -$131K | ﹤0.01% | 5871 |
|
|
2013
Q3 | $182K | Sell |
3,900
-1,300
| -25% | -$62.2K | ﹤0.01% | 4853 |
|
|
2013
Q2 | $254K | Buy |
+5,200
| New | +$249K | ﹤0.01% | 4453 |
|
Other funds holding LPNT
Citadel Advisors's LPNT Position: Q4 2018 in Review
Citadel Advisors sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 9,823 shares — an estimated $633K sold.
Citadel Advisors first reported a position in LPNT in Q2 2013 and held it in 21 quarters. The position peaked at $42.4M in Q2 2016. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.
- Citadel Advisors reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
- Citadel Advisors sold 9,823 LifePoint Health, Inc. shares in Q4 2018, an estimated $633K.
- Citadel Advisors first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 21 quarters.
- Citadel Advisors's LifePoint Health, Inc. position peaked at $42.4M in Q2 2016.
- 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.